Statistics
Publications
3
Citations
105
H-Index
3
Active since
2017
Xu Yongbing is an author at Peking University Shenzhen Hospital specializing in molecular oncology, chromatin biology, and histone demethylase inhibition.
Publications per year
2017–2019
3
3
The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells
Aixia Sui, Xu Yongbing, Yitong Li et al. · Oncotarget · 2017 · 52 citations · Full text
Medicine, Oncology, Pharmacology +13
1–3 of 3